Trilostane

Trilostane can inhibit the synthesis of corticosteroids β- Dehydrogenase, which reduces the synthesis of cortisol and aldosterone, is clinically used to deal with Cushing's syndrome (hypercortisolemia) and most important aldosteronism. However, the efficacy of treating Cushing's syndrome (hypercortisolemia) is now not as suitable as that of metoprolone. This product additionally has a widespread impact on lowering blood testosterone levels, which can also be associated to inhibiting its synthesis.